chrX-85094935-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BS1BS2
The NM_001367857.2(SATL1):c.1755C>T(p.Asn585=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0218 in 1,178,147 control chromosomes in the GnomAD database, including 254 homozygotes. There are 8,287 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.017 ( 19 hom., 549 hem., cov: 23)
Exomes 𝑓: 0.022 ( 235 hom. 7738 hem. )
Consequence
SATL1
NM_001367857.2 synonymous
NM_001367857.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.19
Genes affected
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant X-85094935-G-A is Benign according to our data. Variant chrX-85094935-G-A is described in ClinVar as [Benign]. Clinvar id is 3037120.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=-2.19 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.0168 (1878/111768) while in subpopulation SAS AF= 0.0391 (104/2658). AF 95% confidence interval is 0.033. There are 19 homozygotes in gnomad4. There are 549 alleles in male gnomad4 subpopulation. Median coverage is 23. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 19 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SATL1 | NM_001367857.2 | c.1755C>T | p.Asn585= | synonymous_variant | 5/8 | ENST00000644105.2 | |
SATL1 | NM_001367858.2 | c.1755C>T | p.Asn585= | synonymous_variant | 9/12 | ||
SATL1 | NM_001012980.2 | c.1755C>T | p.Asn585= | synonymous_variant | 3/5 | ||
SATL1 | XM_047442081.1 | c.1755C>T | p.Asn585= | synonymous_variant | 4/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SATL1 | ENST00000644105.2 | c.1755C>T | p.Asn585= | synonymous_variant | 5/8 | NM_001367857.2 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0168 AC: 1880AN: 111715Hom.: 19 Cov.: 23 AF XY: 0.0162 AC XY: 548AN XY: 33919
GnomAD3 genomes
AF:
AC:
1880
AN:
111715
Hom.:
Cov.:
23
AF XY:
AC XY:
548
AN XY:
33919
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0206 AC: 3500AN: 169951Hom.: 34 AF XY: 0.0233 AC XY: 1350AN XY: 57857
GnomAD3 exomes
AF:
AC:
3500
AN:
169951
Hom.:
AF XY:
AC XY:
1350
AN XY:
57857
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0223 AC: 23763AN: 1066379Hom.: 235 Cov.: 24 AF XY: 0.0229 AC XY: 7738AN XY: 337845
GnomAD4 exome
AF:
AC:
23763
AN:
1066379
Hom.:
Cov.:
24
AF XY:
AC XY:
7738
AN XY:
337845
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0168 AC: 1878AN: 111768Hom.: 19 Cov.: 23 AF XY: 0.0162 AC XY: 549AN XY: 33982
GnomAD4 genome
AF:
AC:
1878
AN:
111768
Hom.:
Cov.:
23
AF XY:
AC XY:
549
AN XY:
33982
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
SATL1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 20, 2020 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at